Loading clinical trials...
Loading clinical trials...
This is a study to evaluate the HLA-DRB1\*04:01 genotype in adults that have been diagnosed with type 1 diabetes
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
GentiBio, Inc
NCT07011147 · Type 1 Diabetes (T1D), Type 2 Diabetes, and more
NCT06688331 · Presymptomatic Diabetes Type 1 (Stage 1), Diabetes Mellitus, Type I, and more
NCT02081326 · Diabetes Mellitus, Type One, Diabetes Mellitus, Type I, and more
NCT02088658 · Diabetes Mellitus, Type 2, Diabetes Mellitus, Adult-Onset, and more
NCT06945744 · Diabetes Mellitus, Type I
University of California, San Francisco
San Francisco, California
University of Florida- Gainesville
Gainesville, Florida
Joslin Diabetes Center
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions